Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Kay

Showing results (11-20 of 197) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2007
Combinatorial RNAi: a winning strategy for the race against evolving targets?Dirk Grimm, Mark A Kay
Nature|July 18, 2003
Looking into the safety of AAV vectorsMark A Kay, Hiroyuki Nakai
Hematology. American Society of Hematology. Education Program|November 21, 2007
RNAi and gene therapy: a mutual attractionDirk Grimm, Mark A Kay
Silence|May 13, 2010
How do miRNAs mediate translational repression?Shuo Gu, Mark A Kay
Gene Therapy|November 9, 2002
A story of mice and menAnton P McCaffrey, Mark A Kay
The New England Journal of Medicine|March 7, 2014
Engineering cellular resistance to HIVMark A Kay, Bruce D Walker
The New England Journal of Medicine|August 20, 2015
Viral Vectors Take On HIV InfectionElizabeth D Mellins, Mark A Kay
Human Gene Therapy|January 12, 2017
Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and BeyondPaul N Valdmanis, Mark A Kay
Molecular and Cellular Biology|November 13, 2003
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cellsStephen R Yant, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 4, 2013
The expanding repertoire of circular RNAsPaul N Valdmanis, Mark A Kay
Pageof 20

Showing results (11-20 of 197) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 22, 2007
Combinatorial RNAi: a winning strategy for the race against evolving targets?Dirk Grimm, Mark A Kay
Nature|July 18, 2003
Looking into the safety of AAV vectorsMark A Kay, Hiroyuki Nakai
Hematology. American Society of Hematology. Education Program|November 21, 2007
RNAi and gene therapy: a mutual attractionDirk Grimm, Mark A Kay
Silence|May 13, 2010
How do miRNAs mediate translational repression?Shuo Gu, Mark A Kay
Gene Therapy|November 9, 2002
A story of mice and menAnton P McCaffrey, Mark A Kay
The New England Journal of Medicine|March 7, 2014
Engineering cellular resistance to HIVMark A Kay, Bruce D Walker
The New England Journal of Medicine|August 20, 2015
Viral Vectors Take On HIV InfectionElizabeth D Mellins, Mark A Kay
Human Gene Therapy|January 12, 2017
Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and BeyondPaul N Valdmanis, Mark A Kay
Molecular and Cellular Biology|November 13, 2003
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cellsStephen R Yant, Mark A Kay
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 4, 2013
The expanding repertoire of circular RNAsPaul N Valdmanis, Mark A Kay
Pageof 20